CRISPR Therapeutics (CRSP) PT Lowered to $60 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Form S-3ASR CRISPR Therapeutics AG
August 5, 2024 5:23 PM EDTTable of Contents
As filed with the Securities and Exchange Commission on August 5,... More
Form S-8 CRISPR Therapeutics AG
August 5, 2024 4:55 PM EDT
As filed with the Securities and Exchange Commission on August 5, 2024... More
Form 8-K CRISPR Therapeutics AG For: Aug 05
August 5, 2024 4:05 PM EDTfalse000167441600-000000000016744162024-08-052024-08-05... More
